CELL AND MEMBRANE LIPID ANALYSIS BY PROTON MAGNETIC-RESONANCE SPECTROSCOPY IN 5 BREAST-CANCER CELL-LINES

被引:38
作者
LEMOYEC, L
TATOUD, R
EUGENE, M
GAUVILLE, C
PRIMOT, I
CHARLEMAGNE, D
CALVO, F
机构
[1] IGM,PHARMACOL EXPTL LAB,F-75010 PARIS,FRANCE
[2] HOP LARIBOISIERE,INSERM,U127,F-75475 PARIS 10,FRANCE
关键词
D O I
10.1038/bjc.1992.327
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The lipid composition of five human breast cancer cell lines (MCF-7, T47D, ZR-75-1, SKBR3 and MDA-MB231) was assessed by proton magnetic resonance spectroscopy (MRS) in whole cells and membrane-enriched fractions. The proportions of the three main lipid resonances in 1D spectra were different for each cell line. These resonances included mobile methyl and methylene functions from fatty acids of triglycerides and phospholipids and N-trimethyl from choline of phospholipids. T47D and ZR-75-1 cells presented a high methylene/methyl ratio (6.02 +/- 0.35 and 6.28 +/- 0.90). This ratio was significantly lower for SKBR3, MCF-7 and MDA-MB231 cells (2.76 +/- 0.22, 2.27 +/- 0.57 and 1.39 +/- 0.39). The N-trimethyl/methyl ratio was high for MDA-MB231 and SKBR3 cells (1.38 +/- 0.54 and 0.86 +/- 0.32), but lower for MCF-7, T47D and ZR-75-1 cells (0.49 +/- 0.11, 0.16 +/- 0.07 and 0.07 +/- 0.03). 2D COSY spectra confirmed these different proportions in mobile lipids. From ID spectra obtained on membrane preparations, T47D and ZR-75-1 were the only cell lines to retain a signal from mobile methylene functions. These differences might be related to the heterogeneity found for several parameters of these cells (tumorigenicity, growth rate, hormone receptors); an extended number of cases from fresh samples might enable clinical correlations.
引用
收藏
页码:623 / 628
页数:6
相关论文
共 21 条
[1]   H-1-NMR STUDIES OF HUMAN-BLOOD PLASMA ASSIGNMENT OF RESONANCES FOR LIPOPROTEINS [J].
BELL, JD ;
SADLER, PJ ;
MACLEOD, AF ;
TURNER, PR ;
LAVILLE, A .
FEBS LETTERS, 1987, 219 (01) :239-243
[2]  
BERGELSON L D, 1988, P1
[3]  
CALVO F, 1984, CANCER RES, V44, P4553
[4]   BIOLOGICAL AND NMR MARKERS FOR CANCER [J].
CZUBA, M ;
SMITH, ICP .
PHARMACOLOGY & THERAPEUTICS, 1991, 50 (02) :147-190
[5]  
ENGEL LW, 1978, CANCER RES, V38, P4327
[6]   ROLE OF MEMBRANE-LIPIDS IN THE INTERACTION OF DAUNOMYCIN WITH PLASMA-MEMBRANES FROM TUMOR-CELLS - IMPLICATIONS IN DRUG-RESISTANCE PHENOMENA [J].
ESCRIBA, PV ;
FERRERMONTIEL, AV ;
FERRAGUT, JA ;
GONZALEZROS, JM .
BIOCHEMISTRY, 1990, 29 (31) :7275-7282
[7]   PLASMA-MEMBRANE STUDIES ON DRUG SENSITIVE AND RESISTANT CELL-LINES .4. RUBIDIUM TRANSPORT AND OUABAIN BINDING [J].
GENY, B ;
LELIEVRE, L ;
CHARLEMAGNE, D ;
PARAF, A .
EXPERIMENTAL CELL RESEARCH, 1979, 120 (02) :383-393
[8]   DEVELOPMENT OF THE ACTIVATED HIGH-RESOLUTION H-1 MR SPECTRUM IN MURINE T-CELLS AND B-CELLS OCCURS IN G1 PHASE OF THE CELL-CYCLE [J].
HOLMES, KT ;
LEAN, CL ;
HUNT, NH ;
KING, NJC .
MAGNETIC RESONANCE IN MEDICINE, 1990, 16 (01) :1-8
[9]  
KAPLAN O, 1990, CANCER RES, V50, P544
[10]   N-6 POLYUNSATURATED FATTY-ACIDS IN HUMAN BREAST-CARCINOMA PHOSPHATIDYLETHANOLAMINE AND EARLY RELAPSE [J].
LANSON, M ;
BOUGNOUX, P ;
BESSON, P ;
LANSAC, J ;
HUBERT, B ;
COUET, C ;
LEFLOCH, O .
BRITISH JOURNAL OF CANCER, 1990, 61 (05) :776-778